Beijing Sunshine Novo Pharmaceutical Research Co., Ltd. is a comprehensive CRO company that focuses on the research of generic and innovative drugs, committed to promoting the development of China's pharmaceutical industry with technical services as the core, and providing customers with "preclinical+clinical" full process drug research and development services. The company was established on March 9, 2009, serving Chinese medicine and becoming a leader Being a leading pharmaceutical R&D expert has always been the goal pursued by Novo people. Sunshine Novo has found the best fit from drug discovery, chemical drug and peptide drug development, to the integration of clinical research resources, and the construction of a biological sample testing team, successfully creating a full process CRO service model. The company relies on an excellent and stable R&D team, establishes a sound quality testing and control system, matches the requirements of new drug research and development regulations, and ensures efficient compliance to provide customers with excellent quality Yue's technical services

Sunshine Novo has an experimental area of nearly 10000 square meters,The company has research and development capabilities in chemical drugs and peptide drugs, striving to become the leader in CMC research. In the field of pharmacy, there is an excellent R&D team in clinical CRO research and pharmacokinetic analysis and evaluation, led by experienced technical experts Title. It has four subsidiaries, namely Beijing Nuohe Demei Pharmaceutical Technology Co., Ltd., Beijing Sunshine Demei Pharmaceutical Technology Co., Ltd., Chengdu Nuohe Shengtai Biotechnology Co., Ltd., and Beijing Hongsheng Pharmaceutical Technology Co., Ltd.